| |APRIL 20269NOVARTIS COMMUNITY HEALTH PROGRAMS EXPAND GLOBAL REACHMEDTECH GCC IN INDIA EXPANDS AS ANSR BUILDS GLOBAL INNOVATION HUBNovartis is stepping up efforts to tackle gaps in care with its Novartis community health programs, expanding initiatives aimed at heart disease and cancer in underserved populations.The Novartis community health programs will grow from 11 to more than 30 countries by 2030, focusing on low-income, rural, and hard-to-reach communities where access to care remains limited.The expansion includes three key approaches. Inclusive Health Accelerators (IHAs), launching this week in five US cities, aim to improve access to breast and prostate cancer screening, diagnosis, and follow-up care.Community Health Initiatives (CHIs) will scale across emerging economies to speed up diagnosis and treatment, while CARDIO4Cities will use real-time data and AI to improve heart health in urban areas worldwide."We are going further to bring heart disease and cancer care to communities falling through the gaps in health systems," said Michelle Weese, chief corporate affairs officer at Novartis. "With progress slowing against chronic disease in many countries, and millions missing out on potential treatment, there is an urgent need for new, sustainable solutions to improve access to care."In the US, IHAs will roll out in New York, Los Angeles, Detroit, Houston, and Baltimore, focusing on awareness, free screenings, and faster referrals. In lower-income countries, CHIs are already active in Vietnam, Rwanda, and Bolivia, with plans to expand further. These programs are designed to bring affordable healthcare access, early disease detection, and community-based treatment solutions closer to patients.Meanwhile, CARDIO4Cities is set to expand to 23 countries, building on success in cities like São Paulo and Singapore, where it has improved hypertension control and reduced heart-related risks. POToday news highlights a major shift in India's Global Capability Center ecosystem as ANSR launches a new MedTech GCC in India for a Fortune 100 healthcare company.The MedTech GCC in India is being positioned as a global innovation hub focused on engineering, product development, and digital healthcare platforms.It reflects a growing trend where Fortune 100 MedTech companies are using GCCs in India to accelerate global product engineering and digital transformation. ANSR's role strengthens the GCC India ecosystem further.ANSR is building the center to strengthen India's role in MedTech GCC in India expansion, bringing together cloud computing, AI, machine learning, and data engineering talent.The initiative reflects how GCC India models are shifting from support functions to full-scale product engineering hubs. India's GCC ecosystem continues to attract global investments due to its strong engineering workforce and mature delivery capabilities. This shift highlights India's growing importance as a strategic hub for global healthcare engineering and innovation-led GCC models.The MedTech GCC will focus on AI in healthcare, cloud platforms, and advanced analytics to build secure, scalable systems for global healthcare operations. It will also drive digital health platforms in India, enabling smarter patient care and faster product innovation cycles. These capabilities also strengthen healthcare cloud security and enable AI-driven clinical insights across global systems. It reinforces India's position as a preferred destination for high-value MedTech engineering and product innovation work.Another key focus is wearable technologies and connected care solutions that support real-time health monitoring and patient engagement. This positions India as a rising hub for MedTech innovation and next-generation healthcare delivery. At a global scale, it aims to improve patient outcomes while making healthcare systems more connected and efficient. Digital health adoption in India is accelerating as enterprises invest in platform-led transformation. PO
< Page 8 | Page 10 >